| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| sm-101 | immunoglobulin gamma fc receptor iia | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Immune thrombocytopenic purpura[MeSHID:D016553] Diabetic Nephropathy[MeSHID:D003928] Lupus Erythematosus Systemic[MeSHID:D008180] |
3.03 | approved (orphan drug) | unknown |
| sm-101 | map kinase p38 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Immune thrombocytopenic purpura[MeSHID:D016553] Diabetic Nephropathy[MeSHID:D003928] Lupus Erythematosus Systemic[MeSHID:D008180] |
0.82 | approved (orphan drug) | unknown |
| click here to return to the previous page | ||||||||